Feature Channels:

Clinical Trials

Add to Favorites Subscribe Share
fbshare-Clinical Trials

Showing results

110 of 200
mmc-logo.gif

Relato de caso: Células-tronco são um passo em direção à melhoria da função sensorial motora após lesão medular

Mayo Clinic

As células-tronco derivadas da gordura de um paciente oferecem um passo para melhorar - e não apenas estabilizar - a função motora e sensorial de pessoas com lesões na medula espinhal, de acordo com pesquisas anteriores da Mayo Clinic.

Channels: All Journal News, Clinical Trials, Neuro, Stem Cells,

Released:
10-Dec-2019 4:50 PM EST
mmc-logo.gif

تقرير حالة: الخلايا الجذعية خطوة نحو تحسين الحركة والوظائف الحسية بعد إصابة الحبل النخاعي

Mayo Clinic

تقدم الخلايا الجذعية المأخوذة من دهون المريض خطوة نحو تحسين - وليس مجرد استقرار - في الحركة والوظائف الحسية لمن يعانون من إصابات في الحبل النخاعي، وذلك وفقًا لبحث أولي أجرته Mayo Clinic.

Channels: All Journal News, Clinical Trials, Neuro, Stem Cells,

Released:
10-Dec-2019 4:05 PM EST
Research Results
Newswise: Umsom Researchers to Test Vaccine Designed to Protect Against Serious Illness From Contaminated Food and Water

Umsom Researchers to Test Vaccine Designed to Protect Against Serious Illness From Contaminated Food and Water

University of Maryland School of Medicine

Each year, millions of people contract serious diarrheal illnesses typically from contaminated food and water. Among the biggest causes of diarrheal diseases are the bacteria Shigella and enterotoxigenic Escherichia coli (ETEC), and researchers at the University of Maryland School of Medicine are testing a vaccine designed to offer protection against these serious pathogens.

Channels: All Journal News, Clinical Trials, Food and Water Safety, Vaccines,

Released:
10-Dec-2019 3:40 PM EST
Research Results
mmc-logo.gif

Mayo Clinic, W. L. Gore & Associates announce Avobis Bio, a joint venture for new regenerative therapies

Mayo Clinic

Mayo Clinic and W. L. Gore & Associates Inc., a global materials science company, have formed a joint venture to advance the development of implantable cell therapies to treat debilitating conditions with no cure. Avobis Bio will combine Mayo Clinic's clinical and cell expertise and Gore’s expertise in material sciences to address some of the most challenging medical issues.

Channels: All Journal News, Clinical Trials, Healthcare, Materials Science, Stem Cells,

Released:
10-Dec-2019 11:35 AM EST
Announcement
Newswise: Giving Common Antibiotic Before Radiation May Help Body Fight Cancer
  • Embargo expired:
    9-Dec-2019 4:00 PM EST

Giving Common Antibiotic Before Radiation May Help Body Fight Cancer

Perelman School of Medicine at the University of Pennsylvania

The antibiotic vancomycin alters the gut microbiome in a way that can help prime the immune system to more effectively attack tumor cells after radiation therapy

Channels: All Journal News, Cancer, Clinical Trials, Microbiome, Grant Funded News,

Released:
9-Dec-2019 12:00 AM EST
Announcement
Newswise: Yale Cancer Center study suggests new approaches needed to manage ibrutinib-related toxicities in CLL patients
  • Embargo expired:
    9-Dec-2019 3:45 PM EST

Yale Cancer Center study suggests new approaches needed to manage ibrutinib-related toxicities in CLL patients

Yale Cancer Center

New findings by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers show that as the use of the drug ibrutinib climbs in patients with chronic lymphocytic leukemia (CLL), so do the rates of patients who stop taking the drug.

Channels: All Journal News, Blood, Cancer, Clinical Trials, Pharmaceuticals, Medical Meetings,

Released:
9-Dec-2019 10:50 AM EST
Research Results
Newswise: Research at Argonne's Advanced Photo Source Leads to New Ebola Drug

Research at Argonne's Advanced Photo Source Leads to New Ebola Drug

Argonne National Laboratory

Scientists using specialized beamlines at Argonne's Structural Biology Center (SBC), a facility for macromolecular crystallography at the Advanced Photon Source, derived insights that led to the discovery of a promising new drug for Ebola.

Channels: All Journal News, Clinical Trials, DOE Science News, Infectious Diseases, Pharmaceuticals, Vaccines, Ebola, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), DOE Science News,

Released:
9-Dec-2019 2:45 PM EST
Research Results

Rutgers-led Team Launches Science and Medicine Research Initiative to Transform Health Care in New Jersey

Rutgers University-New Brunswick

At an event Thursday at Rutgers, thought leaders from academia, health care, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state, as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology.

Channels: Clinical Trials, Government/Law, Healthcare, Pharmaceuticals, U.S. Politics, National Institutes of Health (NIH),

Released:
6-Dec-2019 2:05 PM EST
Feature

Law and Public Policy

Newswise: Long-term study finds faster breast cancer radiation treatment as effective as longer course
  • Embargo expired:
    5-Dec-2019 6:30 PM EST

Long-term study finds faster breast cancer radiation treatment as effective as longer course

McMaster University

Approximately half of the patients were randomly assigned whole breast radiation, delivered once per day over three to five weeks. The other half received external beam APBI, considered to be the least invasive approach to partial breast irradiation, which was given twice a day over five to eight days. The study was long-term, with a median followup of 8.6 years.

Channels: All Journal News, Cancer, Clinical Trials, Women's Health,

Released:
4-Dec-2019 10:40 AM EST
Announcement
Newswise: Weight for It: Time-Restricted Eating Benefits Those at Risk for Diabetes, Heart Disease

Weight for It: Time-Restricted Eating Benefits Those at Risk for Diabetes, Heart Disease

University of California San Diego Health

Researchers from University of California San Diego School of Medicine and the Salk Institute for Biological Studies reported a form of intermittent fasting, called time-restricted eating, improved the health of study participants who had been diagnosed with metabolic syndrome.

Channels: All Journal News, Clinical Trials, Diabetes, Health Food, Heart Disease, Weight Loss, Nutrition, Obesity, Staff Picks,

Released:
5-Dec-2019 4:35 PM EST
Research Results

Showing results

110 of 200

Chat now!
3.30544